Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies | Arthritis Research & Therapy | Full Text
Antibody drug development: Targeting CD20 and CD3
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
Cells | Free Full-Text | Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
Effector and regulatory B cells in immune-mediated kidney disease | Nature Reviews Nephrology
CD20 as a gatekeeper of the resting state of human B cells | PNAS
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
International Clinical Cytometry Society
Cluster of Differentiation (CD Markers) Mnemonics | Epomedicine
Frontiers | Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
CD20 Antibody B Cells & Stains for IHC | Biocare Medical
CD20 as a gatekeeper of the resting state of human B cells | PNAS
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases | SpringerLink
T Cell Markers and B Cell Markers
CD antigens expression in B cells | Sino Biological
B Cells - Function, Activation, Lineage & Markers | Bio-Rad
B Cell Overview | Thermo Fisher Scientific - US
JCI Insight - B cell profiling in malaria reveals expansion and remodeling of CD11c+ B cell subsets
Immunohistochemistry showing (A) positive CD20, a marker of B cell... | Download Scientific Diagram
B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
